Ecteinascidin 743 [ET-743] may play an important role in the treatment of soft tissue sarcomas and other cancers

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1240, 2000-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trabectedin: ET 743, Ecteinascidin 743, Yondelis

Drugs in R&D, Vol. 4, Iss. 1, 2003-01 ,pp. : 75-81

Adis International

Access to resources Recommend Favorite

Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766

By Adis International Limited

Drugs in R&D, Vol. 7, Iss. 5, 2006-01 ,pp. : 317-328

Adis International

Access to resources Recommend Favorite

ET-743

By Cvetkovic R.S. Figgitt D.P. Plosker G.L.

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1185-1192

Adis International

Access to resources Recommend Favorite

ET-743: A Viewpoint by Etienne G.C. Brain

By Brain E.G.C.

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1193-1194

Adis International

Access to resources Recommend Favorite

Safety evaluation of trabectedin in treatment of soft-tissue sarcomas

By Martin-Liberal Juan Judson Ian

Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. : 905-911

Informa Healthcare

Access to resources Recommend Favorite